UBS lowers California Resources stock price target on earnings impact By Investing.com

UBS cut its price target on California Resources to $78 from $82 while keeping a Buy rating, citing lower first-quarter 2026 and full-year 2026 estimates due to production sharing contract and hedge impacts. CRC reported Q1 2026 EPS of $0.88 versus $0.80 expected, but revenue came in far below consensus at $119 million versus $930.6 million. The company also signaled a return to growth with plans to add three rigs over the summer, which UBS said should lift production by about 1% from entry to exit.

Analysis

CRC’s setup is less about the near-term print and more about the market re-rating how much of the upside is already embedded after a strong 12-month move. A lower target with a still-positive rating typically signals the sell-side is defending the equity’s structural story while quietly marking down the earnings slope; that matters because E&Ps usually de-rate fastest when growth spending resumes before commodity visibility improves.

The second-order issue is capital discipline versus optionality. Adding rigs into a rising-oil tape can look value-accretive, but if crude softens or hedges roll off unfavorably, the incremental barrels may arrive just as realized pricing compresses, turning “return to growth” into a margin dilution story. That creates asymmetric downside for a levered single-name versus broader upstream baskets, especially if the market starts valuing CRC more like a cash-yield story than a growth story.

The understated catalyst is not production growth itself, but whether management can translate upstream cash flow into proof points for the power and carbon capture assets before sentiment fades. Those units are longer-duration call options, so the stock needs either a sustained Brent floor or a tangible commercial milestone within the next 2-3 quarters; absent that, the equity could remain range-bound even if operationally decent.

Consensus appears to be treating the recent drawdown as a buying opportunity because the shares still screen cheap on forward metrics. The contrarian read is that the market may be underpricing how quickly the Street will move from ‘undervalued’ to ‘value trap’ if revised estimates keep drifting lower while capex steps up. In that scenario, the multiple can compress further even without a fundamental disaster.

Key Decisions for Investors

• Short CRC into strength or sell call spreads into the next 2-6 weeks; the near-term risk/reward is unfavorable if estimate revisions continue and the stock re-rates from ‘cheap growth’ to ‘capital-return hostage.’
• Pair trade: long a diversified upstream basket vs. short CRC over the next 1-3 months; CRC has more idiosyncratic downside from hedge/contract mix and a higher probability of estimate cuts than larger peers.
• If holding CRC, use a collar: own the stock but buy 1-2 month puts financed with out-of-the-money calls; this protects against another downdraft while preserving some upside if Brent stays firm.
• Wait for a post-rig-addition confirmation window before buying; only add after the next operating update proves the production lift is translating into realized cash flow, not just higher capex.
• For event-driven investors, own a small long-dated optionality position only if management gives measurable CCS/power commercialization milestones; otherwise the long thesis is too dependent on sentiment rather than earnings.